During the past decade, Parkview Regional Cancer Center at Parkview Health conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 19 clinical trials were completed, i.e. on average, 126.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 9 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parkview Regional Cancer Center at Parkview Health" #1 sponsor was "Radiation Therapy Oncology Group" with 14 trials, followed by "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Accuray Incorporated" with 2 trials sponsored, "NanOlogy, LLC" with 2 trials sponsored and "Parkview Health" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parkview Regional Cancer Center at Parkview Health" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator and "Seagen Inc." with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Parkview Regional Cancer Center at Parkview Health" are "Lung Cancer" (5 trials), "Prostate Cancer" (3 trials), "Brain and Central Nervous System Tumors" (2 trials), "Breast Cancer" (2 trials) and "Carcinoma, Renal Cell" (2 trials). Many other conditions were trialed in "Parkview Regional Cancer Center at Parkview Health" in a lesser frequency.

Most popular intervention types in "Parkview Regional Cancer Center at Parkview Health" are "Drug" (22 trials), "Radiation" (17 trials), "Procedure" (5 trials), "Biological" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (4 trials), "Placebo" (3 trials), "cetuximab" (3 trials), "cisplatin" (3 trials) and "Belzutifan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Parkview Regional Cancer Center at Parkview Health" are 26 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Parkview Regional Cancer Center at Parkview Health". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Parkview Regional Cancer Center at Parkview Health, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Parkview Regional Cancer Center at Parkview Health, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".